CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical Holding Corp. (OTC:CURR)Β is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilmβ’), one of the most advanced oral thin film on the market today.
CURE is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel and Germany, among other markets. The companyβs mission is to improve peopleβs lives by redefining how medicines are delivered and experienced.